"Together, these highlight the fact that oral corticosteroids contribute to burden, even intermittently used," Oppenheimer ...

For anyone with asthma, keeping symptoms under control can sometimes feel like a constant struggle. Between seasonal weather ...

Professor Kim Kyung-hoon of Pediatrics and Adolescents at Bundang Seoul National University Hospital announced that the use of steroids to treat childhood asthma can increase children's risk of ...

Toddlers with a peanut allergy built tolerance with 3 years of epicutaneous immunotherapy after a year of placebo use, ...

ORLANDO, FL / ACCESS Newswire / November 14, 2025 / RedChip Companies will air interviews with Connect Biopharma Holdings Limited (Nasdaq:CNTB) and Bimergen Energy Corp. (OCTQB:BESS) on the RedChip ...

The summit, bringing together leading domestic and international experts to address critical challenges in respiratory health ...

Researchers at NYU and partners within the International Healthy Outcomes of Pregnancy for Everyone (HOPE) Consortium have ...

GSK’s leadership in respiratory medicine goes beyond science—uniting research, collaboration, and care to transform outcomes ...

While over- and continuous exposure to air pollutants can cause irreversible lung damage and are a risk factor for chronic ...

Benralizumab is an anti-IL-5Ra antibody that causes a nearly complete depletion of eosinophils and has demonstrated ...

But in findings presented at the American College of Allergy, Asthma and Immunology (ACAAI) meeting in Orlando, the novel ...

Siolta Therapeutics, a clinical-stage biotech company developing first-in-class live biotherapeutic products (LBPs), today announced positive top-line results from the Phase 2 ADORED study (Allergic ...